Bora CDMO Bora CDMO

X

Find Radio Compass News for Pseudoephedrine Hydrochloride

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
53
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - 200MG;30MG
  • CAPSULE;ORAL - 8MG;60MG
  • TABLET, EXTENDED RELEASE;ORAL - 240MG
  • TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG
  • CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG
  • TABLET;ORAL - 2MG;200MG;30MG
  • TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG
  • TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG
  • TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG
  • SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML
  • SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • SYRUP;ORAL - 2MG/5ML;10MG/5ML;30MG/5ML

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213565

FDA
10 Mar 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212409

FDA
08 Mar 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-7-2022-68481.pdf

FDA
07 Dec 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211360

FDA
01 Jun 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214407

FDA
01 Feb 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-26-2022-1643358623.pdf

FDA
26 Jan 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202955

FDA
07 Nov 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210647

FDA
17 Jul 2020

https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-teva-cotridin-1591765702.pdf

HEALTH CANADA
10 Jun 2020

https://www.pharmacompass.com/pdf/news/health-canda-issues-recall-of-teva-canadas-ratio-cotridine-1589269316.pdf

HEALTH CANADA
12 May 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212542

FDA
30 Apr 2020

https://apnews.com/fd769fe0f9d417c47a947c12c14ea3bb

Adam Beam AP NEWS
22 Jan 2020

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-26-2019-1561616031.pdf

FDA
26 Jun 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210507

FDA
01 May 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206661

FDA
23 Jan 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207676

FDA
04 Dec 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208369

FDA
05 Jan 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209235

FDA
05 Dec 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209116

FDA
31 Oct 2017

https://www.pharmacompass.com/pdf/news/list-of-off-patent-off-exclusivity-drugs-without-an-approved-generic-1499253832.pdf

FDA
04 Jul 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209008

FDA
14 Jun 2017

http://www.courant.com/politics/capitol-watch/hc-jepsen-drug-settlement-story.html

Russell Blair COURANT
25 May 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206660

FDA
16 May 2017

http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205112

FDA
01 Mar 2017

http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208369

FDA
20 Dec 2016

https://www.pharmacompass.com/pdf/news/acella-pharms-llc-generic-brompheniramine-maleate-dextromethorphan-hydrobromide-pseudoephedrine-hydrochloride-approved-in-us-1474699826.pdf

FDA
20 Sep 2016

http://www.prnewswire.com/news-releases/mission-pharmacal-introduces-two-new-cough-and-cold-medications-300181965.html

PR NEWS WIRE
19 Nov 2015

http://www.bloomberg.com/news/articles/2015-08-28/mylan-shareholders-vote-to-push-ahead-with-hostile-perrigo-deal

Elco Van Groningen And Cynthia Koons BLOOMBERG BUSINESS
29 Aug 2015

https://www.pharmacompass.com/pdf/news/sanofi-allegra-d.pdf

FDA
10 Jun 2015

http://www.prnewswire.com/news-releases/allergan-and-perrigo-announce-first-to-market-launch-of-store-brand-equivalent-to-mucinex-d-600mg-er-tablets-300198533.html

PR NEWS WIRE
04 Jan 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY